147 related articles for article (PubMed ID: 19279330)
1. Gram-positive bacteria enhance HIV-1 susceptibility in Langerhans cells, but not in dendritic cells, via Toll-like receptor activation.
Ogawa Y; Kawamura T; Kimura T; Ito M; Blauvelt A; Shimada S
Blood; 2009 May; 113(21):5157-66. PubMed ID: 19279330
[TBL] [Abstract][Full Text] [Related]
2. TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo.
de Jong MA; de Witte L; Oudhoff MJ; Gringhuis SI; Gallay P; Geijtenbeek TB
J Clin Invest; 2008 Oct; 118(10):3440-52. PubMed ID: 18776939
[TBL] [Abstract][Full Text] [Related]
3. Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria.
Flacher V; Bouschbacher M; Verronèse E; Massacrier C; Sisirak V; Berthier-Vergnes O; de Saint-Vis B; Caux C; Dezutter-Dambuyant C; Lebecque S; Valladeau J
J Immunol; 2006 Dec; 177(11):7959-67. PubMed ID: 17114468
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of Toll-like receptor expression in monocyte-derived Langerhans cell-like cells: implications of low-responsiveness to bacterial components in the epidermal Langerhans cells.
Takeuchi J; Watari E; Shinya E; Norose Y; Matsumoto M; Seya T; Sugita M; Kawana S; Takahashi H
Biochem Biophys Res Commun; 2003 Jul; 306(3):674-9. PubMed ID: 12810071
[TBL] [Abstract][Full Text] [Related]
5. Human Langerhans cells selectively activated via Toll-like receptor 2 agonists acquire migratory and CD4+T cell stimulatory capacity.
Peiser M; Koeck J; Kirschning CJ; Wittig B; Wanner R
J Leukoc Biol; 2008 May; 83(5):1118-27. PubMed ID: 18252867
[TBL] [Abstract][Full Text] [Related]
6. Loss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition.
van der Aar AM; Sylva-Steenland RM; Bos JD; Kapsenberg ML; de Jong EC; Teunissen MB
J Immunol; 2007 Feb; 178(4):1986-90. PubMed ID: 17277101
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 exposure and immune activation enhance sexual transmission of Hepatitis C virus by primary Langerhans cells.
Nijmeijer BM; Sarrami-Forooshani R; Steba GS; Schreurs RR; Koekkoek SM; Molenkamp R; Schinkel J; Reiss P; Siegenbeek van Heukelom ML; van der Valk M; Ribeiro CM; Geijtenbeek TB
J Int AIDS Soc; 2019 Mar; 22(3):e25268. PubMed ID: 30932366
[TBL] [Abstract][Full Text] [Related]
8. Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria.
Elson G; Dunn-Siegrist I; Daubeuf B; Pugin J
Blood; 2007 Feb; 109(4):1574-83. PubMed ID: 17038528
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial peptide LL-37 produced by HSV-2-infected keratinocytes enhances HIV infection of Langerhans cells.
Ogawa Y; Kawamura T; Matsuzawa T; Aoki R; Gee P; Yamashita A; Moriishi K; Yamasaki K; Koyanagi Y; Blauvelt A; Shimada S
Cell Host Microbe; 2013 Jan; 13(1):77-86. PubMed ID: 23332157
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukaemia-derived Langerhans-like cells enhance Th1 polarization upon TLR2 engagement.
Bock S; Murgueitio MS; Wolber G; Weindl G
Pharmacol Res; 2016 Mar; 105():44-53. PubMed ID: 26794428
[TBL] [Abstract][Full Text] [Related]
11. Interoperability of RTN1A in dendrite dynamics and immune functions in human Langerhans cells.
Cichoń MA; Pfisterer K; Leitner J; Wagner L; Staud C; Steinberger P; Elbe-Bürger A
Elife; 2022 Oct; 11():. PubMed ID: 36223176
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of the binding mode of Toll/interleukin-1 receptor (TIR) domain proteins during TLR2 signaling.
Nada M; Ohnishi H; Tochio H; Kato Z; Kimura T; Kubota K; Yamamoto T; Kamatari YO; Tsutsumi N; Shirakawa M; Kondo N
Mol Immunol; 2012 Oct; 52(3-4):108-16. PubMed ID: 22673208
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus-1 acquisition in genital mucosa: Langerhans cells as key-players.
de Jong MA; Geijtenbeek TB
J Intern Med; 2009 Jan; 265(1):18-28. PubMed ID: 19093957
[TBL] [Abstract][Full Text] [Related]
14. Immune activation of vaginal human Langerhans cells increases susceptibility to HIV-1 infection.
van Teijlingen NH; Eder J; Sarrami-Forooshani R; Zijlstra-Willems EM; Roovers JWR; van Leeuwen E; Ribeiro CMS; Geijtenbeek TBH
Sci Rep; 2023 Feb; 13(1):3283. PubMed ID: 36841916
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Female Genital Tract-Derived Dendritic Cell Migration and Activation in Response to Inflammatory Cytokines and Toll-Like Receptor Agonists.
Shey MS; Maharaj N; Archary D; Ngcapu S; Garrett N; Abdool Karim S; Passmore JA
PLoS One; 2016; 11(5):e0155668. PubMed ID: 27171482
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells.
Tada H; Aiba S; Shibata K; Ohteki T; Takada H
Infect Immun; 2005 Dec; 73(12):7967-76. PubMed ID: 16299289
[TBL] [Abstract][Full Text] [Related]
17. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells.
Re F; Strominger JL
J Immunol; 2004 Dec; 173(12):7548-55. PubMed ID: 15585882
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of mast cell IL-6 production by combined toll-like and nucleotide-binding oligomerization domain-like receptor activation.
Haidl ID; McAlpine SM; Marshall JS
Int Arch Allergy Immunol; 2011; 154(3):227-35. PubMed ID: 20861644
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2.
Yoshimura A; Lien E; Ingalls RR; Tuomanen E; Dziarski R; Golenbock D
J Immunol; 1999 Jul; 163(1):1-5. PubMed ID: 10384090
[TBL] [Abstract][Full Text] [Related]
20. TLR activation of Langerhans cell-like dendritic cells triggers an antiviral immune response.
Renn CN; Sanchez DJ; Ochoa MT; Legaspi AJ; Oh CK; Liu PT; Krutzik SR; Sieling PA; Cheng G; Modlin RL
J Immunol; 2006 Jul; 177(1):298-305. PubMed ID: 16785525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
